Adenosine modifies the balance between membrane and soluble forms of Flt-1

Journal of Leukocyte Biology

Volumn 90, Issue 1, 2011, Pages 199-204

  Leonard, Frederique ^a   Devaux, Yvan ^a   Vausort, Melanie ^a   Ernens, Isabelle ^a   Rolland Turner, Magali ^a   Wagner, Daniel R ^a,b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b Centre Hospitalier   (Luxembourg)

Author keywords

Hibernation; Macrophages; Receptors; sFlt 1

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE; HEPARAN SULFATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MEMBRANE FMS LIKE TYROSINE KINASE 1; SMALL INTERFERING RNA; SOLUBLE FMS LIKE TYROSINE KINASE 1; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ACUTE HEART INFARCTION; ANGIOGENESIS; ARTICLE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOBLOTTING; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADENOSINE; CELL MEMBRANE; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; MACROPHAGES; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79959813727     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0910505     Document Type: Article

References (29)

1. Berne, R. M. (1963) Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am. J. Physiol. 204, 317-322.
2. Adair, T. H. (2005) Growth regulation of the vascular system: an emerging role for adenosine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, 283-296.
3. Auchampach, J. A. (2007) Adenosine receptors and angiogenesis. Circ. Res. 101, 1075-1077.
4. Abdollahi, A., Schwager, C., Kleeff, J., Esposito, I., Domhan, S., Peschke, P., Hauser, K., Hahnfeldt, P., Hlatky, L., Debus, J., Peters, J. M., Friess, H., Folkman, J., Huber, P. E. (2007) Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc. Natl. Acad. Sci. USA 104, 12890-12895.
5. Clark, A. N., Youkey, R., Liu, X., Jia, L., Blatt, R., Day, Y. J., Sullivan, G. W., Linden, J., Tucker, A. L. (2007) A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ. Res. 101, 1130-1138.
6. Feoktistov, I., Goldstein, A. E., Ryzhov, S., Zeng, D., Belardinelli, L., Voyno-Yasenetskaya, T., Biaggioni, I. (2002) Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ. Res. 90, 531-538.
7. Feoktistov, I., Ryzhov, S., Goldstein, A. E., Biaggioni, I. (2003) Mast cellmediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ. Res. 92, 485-492.
8. Gu, J. W., Brady, A. L., Anand, V., Moore, M. C., Kelly, W. C., Adair, T. H. (1999) Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells. Am. J. Physiol. 277, H595-H602.
9. Leibovich, S. J., Chen, J. F., Pinhal-Enfield, G., Belem, P. C., Elson, G., Rosania, A., Ramanathan, M., Montesinos, C., Jacobson, M., Schwarzschild, M. A., Fink, J. S., Cronstein, B. (2002) Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am. J. Pathol. 160, 2231-2244.
10. Ernens, I., Leonard, F., Vausort, M., Rolland-Turner, M., Devaux, Y., Wagner, D. R. (2010) Adenosine up-regulates vascular endothelial growth factor in human macrophages. Biochem. Biophys. Res. Commun. 392, 351-356.
11. Kendall, R. L., Thomas, K. A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90, 10705-10709.
12. Ferrara, N., Gerber, H. P., LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
13. May, D., Gilon, D., Djonov, V., Itin, A., Lazarus, A., Gordon, O., Rosenberger, C., Keshet, E. (2008) Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc. Natl. Acad. Sci. USA 105, 282-287.
14. Hochholzer, W., Reichlin, T., Stelzig, C., Hochholzer, K., Meissner, J., Breidthardt, T., Reiter, M., Duehsler, B., Freidank, H., Winkler, K., Twerenbold, R., Mueller, C. (2011) Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. Eur. Heart J. 32, 326-335.
15. Ernens, I., Rouy, D., Velot, E., Devaux, Y., Wagner, D. R. (2006) Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2_ pathway. Circ. Res. 99, 590-597.
16. Van Belle, H., Goossens, F., Wynants, J. (1987) Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am. J. Physiol. 252, H886-H893.
17. Timmers, L., Sluijter, J. P., van Keulen, J. K., Hoefer, I. E., Nederhoff, M. G., Goumans, M. J., Doevendans, P. A., van Echteld, C. J., Joles, J. A., Quax, P. H., Piek, J. J., Pasterkamp, G., de Kleijn, D. P. (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ. Res. 102, 257-264.
18. Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., Sasayama, S. (1998) Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98, 149-156.
19. Wang, Y., Tang, Y., Teng, L., Wu, Y., Zhao, X., Pei, G. (2006) Association of _-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7, 139-147.
20. Tang, A. H., Brunn, G. J., Cascalho, M., Platt, J. L. (2007) Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions. J. Leukoc. Biol. 82, 282-285.
21. Velot, E., Haas, B., Leonard, F., Ernens, I., Rolland-Turner, M., Schwartz, C., Longrois, D., Devaux, Y., Wagner, D. R. (2008) Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages. Cardiovasc. Res. 80, 246-254.
22. Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K. N., Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-552.
23. Ramanathan, M., Luo, W., Csoka, B., Hasko, G., Lukashev, D., Sitkovsky, M. V., Leibovich, S. J. (2009) Differential regulation of HIF-1{_} isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists. J. Leukoc. Biol. 86, 681-689.
24. Nevo, O., Soleymanlou, N., Wu, Y., Xu, J., Kingdom, J., Many, A., Zamudio, S., Caniggia, I. (2006) Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, 1085-1093.
25. Lieb, W., Safa, R., Benjamin, E. J., Xanthakis, V., Yin, X., Sullivan, L. M., Larson, M. G., Smith, H. M., Vita, J. A., Mitchell, G. F., Sawyer, D. B., Vasan, R. S. (2009) Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur. Heart J. 30, 1121-1127.
26. Kim, S. Y., Lee, S. H., Park, S., Kang, S. M., Chung, N., Shim, W. H., Cho, S. Y., Jee, S. H., Manabe, I., Jang, Y. (2011) Vascular endothelial growth factor, soluble fms-like tyrosine kinase 1, and the severity of coronary artery disease. Angiology 62, 176-183.
27. Kodama, Y., Kitta, Y., Nakamura, T., Takano, H., Umetani, K., Fujioka, D., Saito, Y., Kawabata, K., Obata, J. E., Mende, A., Kobayashi, T., Kugiyama, K. (2006) Atorvastatin increases plasma soluble fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction. J. Am. Coll. Cardiol. 48, 43-50.
28. Onoue, K., Uemura, S., Takeda, Y., Somekawa, S., Iwama, H., Nishida, T., Morikawa, Y., Nakagawa, H., Tsutsumi, T., Sung, J. H., Takemoto, Y., Soeda, T., Okayama, S., Ishigami, K., Kawata, H., Horii, M., Nakajima, T., Saito, Y. (2009) Usefulness of soluble fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction. Am. J. Cardiol. 104, 1478-1483.
29. Zentilin, L., Puligadda, U., Lionetti, V., Zacchigna, S., Collesi, C., Pattarini, L., Ruozi, G., Camporesi, S., Sinagra, G., Pepe, M., Recchia, F. A., Giacca, M. (2010) Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J. 24, 1467-1478.